A comprehensive view of pfizer inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Pfizer reports its experimental injectable hemophilia drug marstacimab reduced bleeding frequency without safety concerns in Phase 3 study; marstacimab works by shutting down a protein that impedes blood clotting

Pfizer Submits Patent Application for Benzimidazole Derivatives

US Patent Issued to Pfizer on May 30 for "Purification of antibody drug conjugates using a sodium phosphate gradient" (Massachusetts, New York, Missouri, Connecticut Inventors)

US Patent Issued to Pfizer on May 30 for "Benzimidazole derivative compounds and uses thereof" (Connecticut, Massachusetts, Missouri, Rhode Island Inventors)

Researchers Submit Patent Application, 'Anti-Gucy2c Antibodies And Uses Thereof', for Approval (USPTO 20230146072)

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count